10-Q: Cavitation Technologies Reports Net Income of $352,000 for Six Months Ended December 31, 2024, Driven by Patent Sale

Cavitation Technologies, Inc. reports a net income of $352,000 for the six months ended December 31, 2024, primarily due to a gain on patent assignment to Desmet Ballestra.

Summary

• Cavitation Technologies, Inc. reported a net income of $352,000 for the six months ended December 31, 2024, compared to a net loss of $267,000 for the same period in 2023.
• The increase in net income is primarily attributed to a gain of $880,000 from the patent assignment to Desmet Ballestra.
• Revenue decreased by 60.4% to $76,000 for the six months ended December 31, 2024, compared to $192,000 for the same period in 2023.
• General and administrative expenses increased by 46.1% to $564,000 for the six months ended December 31, 2024.
• Research and development expenses decreased by 33.3% to $24,000 for the six months ended December 31, 2024.
• The company's cash and cash equivalents increased to $681,000 as of December 31, 2024, compared to $179,000 as of June 30, 2024.
• The company's ability to continue as a going concern is dependent on its ability to implement its business plan, which includes increasing revenues by using its Reserved Grant Back License.
• Management plans to focus on water treatment and remediation, agriculture applications, and a business venture with Alchemy Beverages, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the company achieved net income due to a one-time gain, revenue declined significantly, and there are concerns about its ability to continue as a going concern. The company is pursuing new opportunities, but their success is uncertain.

Positives

• The company achieved net income of $352,000 for the six months ended December 31, 2024, a substantial turnaround from the previous year's loss.
• The patent assignment to Desmet Ballestra generated $880,000 in cash, strengthening the company's financial position.
• Cash and cash equivalents increased significantly to $681,000, providing a stronger liquidity position.
• The company retains a worldwide, exclusive, transferable, and royalty-free license to practice and use the Assigned Patents in the fields of water and wastewater processing, recovery, recycling, and purification (including oilfield wastewater), as well as the manufacture, distillation, brewing, enhancement, sale, and marketing of alcoholic beverages (the Licensed Fields).

Negatives

• Revenue decreased significantly by 60.4% to $76,000 for the six months ended December 31, 2024.
• General and administrative expenses increased by 46.1% to $564,000, impacting overall profitability.
• The company's auditor has raised substantial doubt about its ability to continue as a going concern.
• The company incurred a loss from operations of $525,000 for the six months ended December 31, 2024.

Risks

• The company's ability to continue as a going concern is uncertain and dependent on implementing its business plan and securing additional financing.
• Reduced Nano Reactor sales to Desmet may negatively impact future revenue.
• The company faces challenges in expanding and attracting new customers in the water treatment sector.
• The success of the Alchemy Beverages venture and new technologies like Hydro-Plasma is uncertain and may require additional funding.

Future Outlook

Management plans to increase revenues by using its Reserved Grant Back License to apply the technology to water and wastewater processing, recovery, recycling and purification (including oilfield wastewater) and manufacture, distillation, brewing, enhancements, sale and marketing of alcoholic beverages.

Management Comments

• The Company anticipates that sales will be generated in the first half of fiscal 2025 from Water Treatment and Remediation in the Permian Basin.
• The outcome of the trials at Hacienda Farms, which we expect to be completed within the first calendar quarter of 2025, will determine the commercial viability of our product and the timeline for any potential revenue generation.
• The earliest sales and revenue for Barmuze are anticipated in the second half of 2025.
• Testing of the Hydro-Plasma technology is currently underway, and upon completion of multiple trials, if successful, sales and revenue are anticipated in the first half of 2025.

Industry Context

The company is positioning itself to capitalize on the growing demand for sustainable solutions in agriculture and industrial applications, particularly in water treatment and remediation. The global cold plasma market is projected to grow significantly, indicating a potential opportunity for the company's Hydro-Plasma technology.

Comparison to Industry Standards

• It is difficult to compare Cavitation Technologies directly to industry standards due to its unique technology and diverse application areas.
• However, the company's focus on water treatment and remediation aligns with the broader industry trend towards sustainable and environmentally friendly solutions.
• Companies like Ecolab and Veolia are major players in the water treatment industry, but Cavitation Technologies' niche technology may offer a competitive advantage in specific applications.

Related Party Transactions

• Accrued payroll and payroll taxes due to employees, a former officer and current officer and director of the Company totaled $434,000 as of December 31, 2024.

Stakeholder Impact

• Shareholders may be concerned about the company's ability to continue as a going concern and the decline in revenue.
• Employees may be affected by potential cost-cutting measures or changes in the company's strategic direction.
• Customers may benefit from the company's new technologies and applications in water treatment and alcoholic beverage enhancement.
• Suppliers may be impacted by changes in the company's purchasing patterns.

Next Steps

• The company plans to continue testing and developing its water treatment and remediation technologies.
• The company will continue to work with Alchemy Beverages, Inc. to commercialize the Barmuze appliance.
• The company will seek additional funding to support its operations and growth initiatives.

Key Dates